An In Vivo Study of Low-Dose Intra-Articular Tranexamic Acid Application with Prolonged Clamping Drain Method in Total Knee Replacement: Clinical Efficacy and Safety

Paphon Sa-ngasoongsong, Pongsthorn Chanplakorn, Siwadol Wongsak, Krisorn Uthadorn, Tanapong Panpikoon, Paisan Jittorntam, Katcharin Aryurachai, Pantap Angchaisukisiri, Viroj Kawinwonggowit, Paphon Sa-ngasoongsong, Pongsthorn Chanplakorn, Siwadol Wongsak, Krisorn Uthadorn, Tanapong Panpikoon, Paisan Jittorntam, Katcharin Aryurachai, Pantap Angchaisukisiri, Viroj Kawinwonggowit

Abstract

Background: Recently, combined intra-articular tranexamic acid (IA-TXA) injection with clamping drain method showed efficacy for blood loss and transfusion reduction in total knee replacement (TKR). However, until now, none of previous studies revealed the effect of this technique on pharmacokinetics, coagulation, and fibrinolysis.

Materials and methods: An experimental study was conducted, during 2011-2012, in 30 patients undergoing unilateral TKR. Patients received IA-TXA application and then were allocated into six groups regarding clamping drain duration (2-, 4-, 6-, 8-, 10-, and 12-hours). Blood and drainage fluid were collected to measure tranexamic acid (TXA) level and related coagulation and fibrinolytic markers. Postoperative complication was followed for one year.

Results: There was no significant difference of serum TXA level at 2 hour and 24 hour among groups (p < 0.05). Serum TXA level at time of clamp release was significantly different among groups with the highest level at 2 hour (p < 0.0001). There was no significant difference of TXA level in drainage fluid, postoperative blood loss, blood transfusion, and postoperative complications (p < 0.05).

Conclusions: Low-dose IA-TXA application in TKR with prolonged clamping drain method is a safe and effective blood conservative technique with only minimal systemic absorption and without significant increase in systemic absorption over time.

Figures

Figure 1
Figure 1
Serum tranexamic acid (TXA) level at time of clamp release and 24 hours in each group.

References

    1. Allain J., Stramer S. L., Carneiro-Proietti A., et al. Transfusion-transmitted infectious diseases. Biologicals. 2009;37(2):71–77. doi: 10.1016/j.biologicals.2009.01.002.
    1. Vamvakas E. C., Blajchman M. A. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406–3417. doi: 10.1182/blood-2008-10-167643.
    1. Ishida K., Tsumura N., Kitagawa A., et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. International Orthopaedics. 2011;35(11):1639–1645. doi: 10.1007/s00264-010-1205-3.
    1. Maniar R. N., Kumar G., Singhi T., Nayak R. M., Maniar P. R. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clinical Orthopaedics and Related Research. 2012;470(9):2605–2612. doi: 10.1007/s11999-012-2310-y.
    1. Onodera T., Majima T., Sawaguchi N., Kasahara Y., Ishigaki T., Minami A. Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. The Journal of Arthroplasty. 2012;27(1):105–108. doi: 10.1016/j.arth.2011.02.004.
    1. Sa-Ngasoongsong P., Channoom T., Kawinwonggowit V., et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthopedic Reviews. 2011;3(2, article e12) doi: 10.4081/or.2011.e12.
    1. Sa-Ngasoongsong P., Wongsak S., Chanplakorn P., et al. Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. BMC Musculoskeletal Disorders. 2013;14(1, article 340) doi: 10.1186/1471-2474-14-340.
    1. Seo J.-G., Moon Y.-W., Park S.-H., Kim S.-M., Ko K.-R. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy. 2013;21(8):1869–1874. doi: 10.1007/s00167-012-2079-2.
    1. Kiely N., Hockings M., Gambhir A. Does temporary clamping of drains following knee arthroplasty reduce blood loss? A randomised controlled trial. Knee. 2001;8(4):325–327. doi: 10.1016/S0968-0160(01)00095-3.
    1. Madadi F., Mehrvarz A. S., Madadi F., Boreiri M., Abachizadeh K., Ershadi A. Comparison of drain clamp after bilateral total knee arthroplasty. The Journal of Knee Surgery. 2010;23(4):215–221. doi: 10.1055/s-0031-1271891.
    1. Shen P.-C., Jou I.-M., Lin Y.-T., Lai K.-A., Yang C.-Y., Chern T.-C. Comparison between 4-hour clamping drainage and nonclamping drainage after total knee arthroplasty. Journal of Arthroplasty. 2005;20(7):909–913. doi: 10.1016/j.arth.2005.01.017.
    1. Stucinskas J., Tarasevicius S., Cebatorius A., Robertsson O., Smailys A., Wingstrand H. Conventional drainage versus four hour clamping drainage after total knee arthroplasty in severe osteoarthritis: a prospective, randomised trial. International Orthopaedics. 2009;33(5):1275–1278. doi: 10.1007/s00264-008-0662-4.
    1. Roy N., Smith M., Anwar M., Elsworth C. Delayed release of drain in total knee replacement reduces blood loss. A prospective randomised study. Acta Orthopaedica Belgica. 2006;72(1):34–38.
    1. Ahlbäck S. Osteonecrosis of the knee. Calcified Tissue Research. 1968;2(1):p. 36. doi: 10.1007/BF02065218.
    1. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American society of anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. Anesthesiology. 2006;105(1):198–208.
    1. Chang Q., Yin O. Q., Chow M. S. S. Liquid chromatography-tandem mass spectrometry method for the determination of tranexamic acid in human plasma. Journal of Chromatography B. 2004;805(2):275–280. doi: 10.1016/j.jchromb.2004.03.013.
    1. Delyle S. G., Abe E., Batisse A., et al. A validated assay for the quantitative analysis of tranexamic acid in human serum by liquid chromatography coupled with electrospray ionization mass spectrometry. Clinica Chimica Acta. 2010;411(5-6):438–443. doi: 10.1016/j.cca.2010.01.005.
    1. Robinson J. D., Lupkiewicz S. M., Palenik L., Lopez L. M., Ariet M. Determination of ideal body weight for drug dosage calculations. American Journal of Hospital Pharmacy. 1983;40(6):1016–1019.
    1. Seeber P., Shander A. Basics of Blood Management. 1st. Malden, Mass, USA: Blackwell Publishing; 2007.
    1. Blanié A., Bellamy L., Rhayem Y., et al. Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thrombosis Research. 2013;131(1):e6–e11. doi: 10.1016/j.thromres.2012.11.006.
    1. Abdel-Salam A., Eyres K. S. Effects of tourniquet during total knee arthroplasty. A prospective randomised study. The Journal of Bone and Joint Surgery—British Volume. 1995;77(2):250–253.
    1. Eriksson B. I., Hultman E., Martinell S., Eriksson E., Tengborn L., Risberg B. Regional fibrinolysis following total hip replacement. Thrombosis Research. 1991;62(5):441–447. doi: 10.1016/0049-3848(91)90017-q.
    1. Sørensen J. V., Borris L. C., Lassen M. R., et al. Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis-influence of prophylaxis with a low molecular weight heparin. Thrombosis Research. 1990;59(1):131–138. doi: 10.1016/0049-3848(90)90278-k.
    1. Festa A., Williams K., Tracy R. P., Wagenknecht L. E., Haffner S. M. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation. 2006;113(14):1753–1759. doi: 10.1161/CIRCULATIONAHA.106.616177.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir